Publications by authors named "William Rees"

Claim this Profile
D
Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand.
Annie Lau-Kilby, Michele Gunsior, Agata Bartczak, Susan Chyou, James Hester, William A Rees

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity.
Jeffrey L Bennett, Sean J Pittock, Friedemann Paul, Ho Jin Kim, Sarosh R Irani, William A Rees

Ann Clin Transl Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Bruce A C Cree, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk, William Rees

Lancet Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial.
E William St Clair, Alan N Baer, Wan-Fai Ng, Ghaith Noaiseh, Chiara Baldini, William A Rees

Nat Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
Laura Cook, May Q Wong, William D Rees, Alana Schick, Daniel J Lisko

Inflamm Bowel Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet and deprivation in pregnancy: a rat model to investigate the effects of the maternal diet on the growth of the dam and its offspring.
Halil Dasgin, Susan M Hay, William D Rees

Br J Nutr· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Ho Jin Kim, Orhan Aktas, Kristina R Patterson, Schaun Korff, Amy Kunchok, William A Rees

Ann Clin Transl Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
World scientists' warning: The behavioural crisis driving ecological overshoot.
Joseph J Merz, Phoebe Barnard, William E Rees, Dane Smith, Mat Maroni

Sci Prog· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
Orhan Aktas, Hans-Peter Hartung, Michael A Smith, William A Rees, Kazuo Fujihara

J Neurol Neurosurg Psychiatry· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Brian G Weinshenker, Dean M Wingerchuk, Ari J Green, Jeffrey L Bennett, Ho Jin Kim, William Rees

Mult Scler· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flagellin-specific human CAR Tregs for immune regulation in IBD.
Dominic A Boardman, May Q Wong, William D Rees, Dan Wu, Megan E Himmel

J Autoimmun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.
Jeffrey L Bennett, Orhan Aktas, William A Rees, Michael A Smith, Michele Gunsior

EBioMedicine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication.
Tirosh Shapira, Selvarani Vimalanathan, Celine Rens, Virginia Pichler, Sandra Peña-Díaz, William Rees

Mol Biomed· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientists' warning on population.
Eileen Crist, William J Ripple, Paul R Ehrlich, William E Rees, Christopher Wolf

Sci Total Environ· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic modelling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders.
Li Yan, Bing Wang, Dewei She, Ben Mitchell, Ryan Criste, William A Rees

Br J Clin Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.
Tirosh Shapira, I Abrrey Monreal, Sébastien P Dion, David W Buchholz, Brian Imbiakha, William D Rees

Nature· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis.
Li Yan, Holly Kimko, Bing Wang, Daniel Cimbora, Eliezer Katz, William A Rees

Clin Pharmacokinet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in vitro chronic damage model impairs inflammatory and regenerative responses in human colonoid monolayers.
William D Rees, Nikita Telkar, David T S Lin, May Q Wong, Chad Poloni

Cell Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Romain Marignier, Sean J Pittock, Friedemann Paul, Ho Jin Kim, Jeffrey L Bennett, William Rees

Mult Scler Relat Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Bruce Ac Cree, Jeffrey L Bennett, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, William Rees

Mult Scler· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
World scientists' warnings into action, local to global.
Phoebe Barnard, William R Moomaw, Lorenzo Fioramonti, William F Laurance, Mahmoud I Mahmoud, William E Rees

Sci Prog· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
Orhan Aktas, Michael A Smith, William A Rees, Jeffrey L Bennett, Dewei She

Ann Neurol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder.
Romain Marignier, Jeffrey L Bennett, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, William Rees

Neurol Neuroimmunol Neuroinflamm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice.
Tirosh Shapira, I Abrrey Monreal, Sébastien P Dion, Mason Jager, Antoine Désilets, William D Rees

bioRxiv· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus.
Jodi L Karnell, Yanping Wu, Nanette Mittereder, Michael A Smith, Michele Gunsior, William A Rees

Sci Transl Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis